ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials. Research is being conducted in collaboration with the FNIH Biomarkers Consortium. February 20 ...

The U.S. FDA has selected Icon to validate three patient-reported outcome (PRO) instruments used to assess clinical endpoints in antibacterial drug trials. With the help of the Biomarkers ...

In today’s digital systems, vast volumes of information are produced daily. However, simply collecting large amounts of data is not enough. That data must be reliable and well-structured to serve any ...

In data privacy, a third-party validation shows that a company has a thorough understanding of the sensitivities surrounding data and that stringent processes have been put in place to ensure ...

ALLSCHWIL, Switzerland, March 29, 2022 /PRNewswire/ -- BioCopy AG introduces ValidaTe, an innovative, proprietary platform based on microarrays for the highly parallelized screening of drug ...